Terms like “narcissist,” “trigger” and “gaslighting” that were once only used in a shrink’s office have increasingly made ...

Red light therapy is growing in popularity, but not all devices will fit your needs. Here are our top home and clinical-style ...

I’ll cover what I have learned about the Hooga PRO300 after testing it, where it feels more budget than premium, and how easy ...

Israeli Prime Minister Benjamin Netanyahu was treated for early-stage prostate cancer 18 months ago, he revealed Friday, saying he delayed making the news public so Iran would not use it as ...

Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 trial in metastatic hormone-sensitive prostate cancer (mHSPC). The phase 3 Talapro-3 trial met its primary ...

Prostate cancer is the most common cancer to affect American men, besides skin cancer. The American Cancer Society estimates that 1 in 8 men will be diagnosed with prostate cancer at some point in ...

SAN FRANCISCO -- Adding hormone therapy to postoperative radiotherapy did not improve overall survival (OS) for most men with prostate cancer, according to a meta-analysis of individual patient data.

In a new study, researchers found microplastics deep inside prostate cancer tumors, raising more questions about the role the ubiquitous pollutants play in public health. Subscribe to read this story ...

Cleveland Clinic recently became the first health system in the U.S. to use a new robotic-assisted surgery system for prostatectomy. The FDA approved the Hugo RAS system in December. The system ...

NHS England has given the green light for abiraterone to be used to treat men with prostate cancer that has not metastasised. It is the first time the drug will be available for these patients in ...